Back to trial detailsIntake questionnaire
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Applying to Welch Cancer Center · Sheridan, Wyoming
Answer a few short questions to share with the research team.
0 of 3 answered